FDA.reportPublic FDA data

bismuth subsalicylate 525 MG Oral Powder

RxCUI
1191695
RxNorm name
bismuth subsalicylate 525 MG Oral Powder
Term type
SCD
Status
Active
Updated
2026-10-13 14:20:33

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122011
Active start
122011
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
bismuth subsalicylate525 MG / 1 EACHbismuth subsalicylatebismuth subsalicylate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Powder346289

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bismuth subsalicylate19478

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRbismuth subsalicylate 525 MG Oral Powder1NAMES
RxNorm Namebismuth subsalicylate 525 MG Oral Powder1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_IDa019eedf-073d-43c6-ad30-dedb9dd51fbd1CODES
RxCUI11916951CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 5 matching rows.

NDC11, Source, Active table
NDC11SourceActive
51596000401rxnav_ndcsyes
51596000405rxnav_historical
51596000410rxnav_historical
51596000412rxnav_historical
51596000424rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a019eedf-073d-43c6-ad30-dedb9dd51fbdbismuth subsalicylate 525 MG Oral Powder [PSN] · bismuth subsalicylate 525 MG Oral Powder [SCD]24Upset Stomach Relief to Go ™20141008

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
a019eedf-073d-43c6-ad30-dedb9dd51fbdUpset Stomach Relief to Go ™Breakthrough Products Inc.20141008

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
FDASPLD001729BismuthCHEMhas_chemical_structurebismuth subsalicylate
FDASPLN0000180183BismuthEPChas_epcbismuth subsalicylate
MEDRTD001729BismuthCHEMhas_ingredientbismuth subsalicylate
MEDRTD009942Organometallic CompoundsCHEMhas_ingredientbismuth subsalicylate
MEDRTD012459SalicylatesCHEMhas_ingredientbismuth subsalicylate
MEDRTD001778Blood Coagulation DisordersDISEASEci_withbismuth subsalicylate
MEDRTD002644ChickenpoxDISEASEci_withbismuth subsalicylate
MEDRTD003967DiarrheaDISEASEmay_treatbismuth subsalicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withbismuth subsalicylate
MEDRTD004405Dysentery, BacillaryDISEASEmay_treatbismuth subsalicylate
MEDRTD004415DyspepsiaDISEASEmay_treatbismuth subsalicylate
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatbismuth subsalicylate
MEDRTD006471Gastrointestinal HemorrhageDISEASEci_withbismuth subsalicylate
MEDRTD016481Helicobacter InfectionsDISEASEmay_treatbismuth subsalicylate
MEDRTD009325NauseaDISEASEmay_treatbismuth subsalicylate
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withbismuth subsalicylate
MEDRTD013272Stomach DiseasesDISEASEmay_treatbismuth subsalicylate
MEDRTD014777Virus DiseasesDISEASEmay_treatbismuth subsalicylate
MEDRTN0000000226Acid-Base ActivityMOAhas_moabismuth subsalicylate
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moabismuth subsalicylate
MEDRTN0000009724Inhibition Gastric Acid SecretionPEhas_pebismuth subsalicylate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH525 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymbismuth subsalicylate 525 MG Oral Powder
SOURCESSourceMetathesaurus FDA Structured Product Labels